#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Intracranial germ cell tumour Marginal zone lymphoma refractory Progressive familial intrahepatic cholestasis Immune thrombocytopenia Epidermolysis bullosa Chorioretinitis Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Gastrointestinal stromal tumour Follicle centre lymphoma follicular grade I, II – III Alport's syndrome Parkinson's disease Fms-like tyrosine kinase 3 positive Thrombotic thrombocytopenic purpura Hypochromic anaemia Diabetes insipidus More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Treatment Stevens-Johnson syndrome – Basic Information Acquired haemophilia – Basic Information Lennox-Gastaut syndrome – Trials in Disease Mantle cell lymphoma stage IV – Diagnostics Epidermolysis bullosa – Life with Disease Mucopolysaccharidosis I – Diagnostics Friedreich’s ataxia – Life with Disease Carcinoid syndrome – Basic Information Hairy cell leukaemia recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSK5784283 Dexamethasone Sodium Phosphate Phenylbutyrate Belimumab Tiotropium Bromide Monohydrate Voxelotor Syn321 Oxacillin Ganciclovir Sodium Levodopa Olorofim Ezetimibe Setmelanotide Setanaxib Omp11 Interleukin-2 Umeclidinium Bromide Ngi226 LY3537031 Treosulfan More therapies…

    Learn about Your Condition

    Cachexia Schizophrenia Gastrectomy Diarrhoea Dupuytren's contracture Ependymoma malignant Von Hippel-Lindau disease Ventricular extrasystoles Atopic keratoconjunctivitis Cervix carcinoma stage I Kaposi's sarcoma Corneal graft failure Arteriosclerosis ROHHAD syndrome Oral neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Universitetssykehuset Nord-Norge HF

Universitetssykehuset Nord-Norge HF

Hansine Hansens Veg 67, Tromsø, 9019, Norway

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Guselkumab
    Austria Belgium France Italy The Netherlands Norway +3

  • Study on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Capmatinib
    • Ceritinib
    • Pemigatinib
    Norway

  • Study of azacitidine combined with low-dose venetoclax treatment for patients with acute myeloid leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cedazuridine
    • Decitabine
    • Venetoclax
    Denmark Finland Norway Sweden

  • Study on Treatment Strategies for Children and Adolescents with Juvenile Idiopathic Arthritis Using Methotrexate and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Etanercept
    • Methotrexate
    • Adalimumab
    Norway

  • Study on Bortezomib and Temozolomide for Patients with Recurrent Grade IV Glioma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant glioma
    Investigated Drugs:
    • Temozolomide
    • Bortezomib
    Norway

  • Study on Metyrapone for Patients with Mild Autonomous Cortisol Secretion

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperadrenocorticism
    • Cortisol abnormal
    Investigated Drugs:
    • Metyrapone
    Norway

  • A Study of FOLFIRINOX Drug Combination Before Surgery Compared to Immediate Surgery in Patients with Resectable Pancreatic Head Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    Norway Sweden

  • Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Daunorubicin, Mitoxantrone, and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Daunorubicin Hydrochloride
    • Mitoxantrone
    • Cytarabine
    Belgium Denmark Finland The Netherlands Norway Spain +1

  • Study Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Abatacept
    • Azathioprine
    • Betamethasone Sodium Phosphate
    Denmark Iceland Norway Sweden

  • Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dinutuximab Beta
    • Irinotecan Hydrochloride Trihydrate
    • Temozolomide
    Austria Belgium Czechia Denmark Finland France +13
Previous Page
1 2 3 4 5 6 … 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!